Last reviewed · How we verify
Nitrofurantoin or Trimethoprim or Cefalexin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Nitrofurantoin or Trimethoprim or Cefalexin (Nitrofurantoin or Trimethoprim or Cefalexin) — Newcastle-upon-Tyne Hospitals NHS Trust.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nitrofurantoin or Trimethoprim or Cefalexin TARGET | Nitrofurantoin or Trimethoprim or Cefalexin | Newcastle-upon-Tyne Hospitals NHS Trust | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nitrofurantoin or Trimethoprim or Cefalexin CI watch — RSS
- Nitrofurantoin or Trimethoprim or Cefalexin CI watch — Atom
- Nitrofurantoin or Trimethoprim or Cefalexin CI watch — JSON
- Nitrofurantoin or Trimethoprim or Cefalexin alone — RSS
Cite this brief
Drug Landscape (2026). Nitrofurantoin or Trimethoprim or Cefalexin — Competitive Intelligence Brief. https://druglandscape.com/ci/nitrofurantoin-or-trimethoprim-or-cefalexin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab